Changshu, China

Changxue Lin



 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Changxue Lin: Innovator in Chemical Processes

Introduction

Changxue Lin is a notable inventor based in Changshu, China. He has made significant contributions to the field of chemistry, particularly in the development of innovative chemical processes. His work has led to advancements in the preparation of spiroindolone compounds, which are important in various applications.

Latest Patents

Changxue Lin holds a patent for a chemical process for preparing spiroindolones and intermediates thereof. The patent details processes and intermediates useful for the manufacture of spiroindolone compounds, such as (1'R,3′S)-5,7′-dichloro-6′-fluoro-3′-methyl-2′,3′,4′,9′-tetrahydrospiro[indoline-3,1′-pyrido[3,4-b]indol]-2-one and its salts, hydrates, and solvates. This innovation showcases his expertise in chemical synthesis and compound development.

Career Highlights

Changxue Lin is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work has been instrumental in advancing the company's portfolio of pharmaceutical products.

Collaborations

Changxue Lin has worked alongside notable colleagues, including Michael Crowe and Michael Foulkes. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Changxue Lin is a distinguished inventor whose contributions to chemical processes have made a lasting impact. His patent for spiroindolone compounds exemplifies his innovative spirit and dedication to advancing science. His work at Novartis AG further highlights his commitment to improving healthcare through research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…